Horizon Discovery

09/05/2023

We have bittersweet news. Today, we chart a new course as Revvity. Stay apprised of our latest and greatest developments via a new, dedicated, life sciences handle https://www.linkedin.com/showcase/revvity-for-life-sciences

As such, this channel is now riding off into the sunset and will no longer be posting any content or updates.

09/05/2023

Don't forget to join us tomorrow for a FREE webinar where Director of Cell-Based Screening, Dr. David Sorrell, will introduce Horizon's OncoSignature™ Long-Term Assay development and its ability to profile slower acting and epigenetic drugs. Register here:

https://bit.ly/40gYxaR

09/05/2023

Interested in mechanisms? Wondering how screens can help? In our latest whitepaper, read an interview with Horizon’s Manager of Cell Based Screening, Verena Brucklacher-Waldert, as she details this exciting topic:

https://bit.ly/42Ffi13

08/05/2023

We appreciate your long-time interest and dedicated following. However, we'll soon be sharing our content on a new focused channel with a few of our closest friends. Keep an eye out as it will be happening very, very, soon.

08/05/2023

Horizon is seeking Senior Scientist 1 with a focus on Molecular Biology, and another in Cell Biology at our Cambridge, UK site!

Apply your expertise of gene editing, cell culture, and molecular biology to undertake specialist tasks, troubleshoot, quality assurance, and promote continuous improvement. See the full job descriptions and apply today:

https://bit.ly/3WRUfFG

08/05/2023

Are you attending this week? Make sure to visit with us at the day 1 reception and enjoy a signature cocktail, "The Dharmacon 2'ACE Swizzle". Informa Connect Life Sciences

https://bit.ly/3LIXpHN

05/05/2023

Get tips on how to elevate your experiments with ™ custom oligonucleotides with our new video series!

Looking to modify your oligo, but you’re unsure of where to start? In episode three, we share considerations where to label or modify your custom oligo. Watch here:

https://bit.ly/42kzrt0

Learn more at: https://horizondiscovery.com/en/dharmaconDharmacon™ custom oligonucleotides are the premier choice whether you need custom siRNA, antisense ol...

04/05/2023

Monoclonal antibodies (mAbs) are a powerful tool in medicine, but improving their potency can enhance treatment outcomes.

In this fascinating article from The Medicine Maker, learn of one promising approach that involves taking genetically modified CHO cells to produce afucosylated antibodies with enhanced ADCC activity. Read the full article here:

https://bit.ly/3Vx5QKw

04/05/2023

Did you know that the iconic duo of C3PO and R2D2 from Star Wars have also inspired the names of proteins in the field of science? These proteins play a crucial role as "helpers" in the RNA pathway.

So this , remember that C3PO and R2D2 aren't just on the big screen, but also in the fascinating world of science!

https://bit.ly/39C7Kpu

04/05/2023

Only one week until this FREE webinar introducing Horizon's OncoSignature™ Long-Term Assay! Join Director of Cell-Based Screening, Dr. David Sorrell, as he dives into the assay’s development and its ability to profile slower acting and epigenetic drugs. Register here:

https://bit.ly/40gYxaR

02/05/2023

Reveal the function of essential genes with our essential CRISPR reagent: inducible Cas9. In this week's , see how inducible Cas9 places control of gene editing in your hands:

https://bit.ly/3nqITwc

28/04/2023

Drive efficiencies during biotherapeutic development and production with Horizon’s CHOSOURCE™ GS KO Expression Platform.

With an industry proven track record, these easy-to-use knockout cells have the ability to reach high expression levels giving you the results you need with less hassle. Learn more:

https://bit.ly/3GZ12HX